Summary.-Moloney sarcoma-virus (MSV)-induced tumours in A/Sn mice have been dispersed with collagenase and DNase 8-15 days after virus inoculation, and both "sarcoma" and inflammatory cells separated by sedimentation velocity and adherence techniques. The isolated "sarcoma" cells had the morphological characteristics of atypical cells (i.e. cytoplasmic blebbing, vacuolization and prominent nucleoli) and were easily adapted to in vitro growth. As few as 2 x 103 of these cells inoculated i.m. produced new tumours within 8 days of injection in both syngeneic and allogeneic mice. Also, cell-free supernatant from "sarcoma"-cell cultures produced tumours, indicating that the successful transplantation of the "sarcoma" cells was probably due to production of infective virus. Cells cytotoxic in vitro against the ''sarcoma'' cells were present within both spleen and tumour of the tumour donors, but not in the spleens of normal mice. The cytotoxicity was specific against virusinfected cells, since in a mixture of virus-positive (gp 70) and virus-negative cells, positive cells were removed while negative cells were not affected, as measured by a visual cytotoxicity assay using immunostaining. Although T cells could be isolated from the MSV-induced tumours, these cells did not appear to mediate the cytotoxicity detected against the MSV "sarcoma" cells. These results suggest that early MSV infections might be sensitive to cytotoxic mechanisms distinct from those reported with established MLV-or MSV-induced tumour lines.
I.M. INJECTION of Moloney murine sarcoma virus (MSV) leads to the development of a tumour within 6-8 days. In immunocompetent mice the tumour regresses within 20 days. The nature of the tumour is, however, subject to controversy. It has been classified as a true malignancy (Perk & Moloney, 1966) as well as a reparative granulomatous process (Stanton et al., 1968; Siegler, 1970) . The regression of the lesion is T-cell-dependent Gorezynski, 1974; Stutman, 1.975) and cytotoxic T cells have been found in lymphoid organs and blood as well as within the tumour mass in C57BL and BALB/c mice (Plata & Sordat, 1977; Holden et al., 1976; Gillespie et al., 1977) . Thus cytotoxic T cells are considered to play an important role in regression.
In the A/Sn mouse strain we have been unable to demonstrate cytotoxic T cells during MSV-induced tumour development and regression, using syngeneic established MLV-induced lymphoma lines as target cells (Becker & Klein, 1976 . As these cells need not be the correct targets for the demonstration of cytotoxic T cells in this strain, though suitable in other strains (Plata & Sordat, 1977; Holden et al., 1976; Gillespie et al., 1977) , we made an effort to isolate the in vivo target cells for the virus to use as in vitro targets in the cytotoxicity tests of the inflammatory cells isolated from the tumours. In this paper, we describe some properties of the MSV "sarcoma"* cells which qualify them as target cells for the in vitro testing. We demonstrate that cytotoxic effector cells with specificity for virus-infected cells can be isolated, and confirm our previous observation that cytotoxic T MSV-Induced tumour suspensions .-MSV tumours 10-1" days after MSV injection were aseptically removed and the tumours were sliced into small 2-3mm pieces. This material was treated with 0-14% collagenase containing 0.05%0 DNase for 20 min, washed with medium, and the process repeated until most of the material was digested.
Sedimentation-velocity separation.-Suspensions of the enzyme-dispersed tumours were resuspended to 1.5 x 106 cells/ml in MEM 5% FCS and sedimented at unit gravity over a continuous 10-25% FCS in MEM at pH 7-4 for 2 h, as described by Miller and Phillips (1969 (Korn et al., 1978 (Korn et al., 1978) . Characterization of the presumptive sarcoma cells Cells sedimenting at 8-12 mm/h consisted of both large macrophages and atypical cells (Fig. 1) . EA rosetting of the fractions showed that the atypical cells did not express FcR (cytocentrifuge preparations made on the rosetted material) and thus could be purified from the contaminating macrophages by FicollHypaque separation of the rosetted material. The atypical cells could also be separated from the macrophages by a brief incubation (30 min) in carbonyl iron. The purified "sarcoma" cells showed cytoplasmic blebbing and were frequently highly vacuolated; the large nuclei had prominent nucleoli (Fig. 2) . After overnight incubation in culture dishes or in the microcytotoxicity test, these cells were 90% homogeneous in gross morphology and fibroblastic in appearance. The plating efficiency varied from 10 to 30%. After 24 h in culture, 25-35% of the adherent "sarcoma" cells were highly virus+, as determined by the immunoperoxidase-bridge technique (data not shown). The purified "sarcoma" cells were easily maintained in tissue culture.
To test the tumorigenicity of the freshly isolated "sarcoma" cells, graded doses of ''sarcoma'' cells were injected into the hind leg of A/Sn mice (Table I) . (Table I) . Thus, infective virus was released from the growing "sarcoma" cells.
Identification of cytotoxic effector cells within the tumour Since cell-mediated cytotoxic mechanisms presumably are important in the regression of MSV tumours, it was of great interest to see whether in vitro cytotoxicity could be demonstrated against the autologous "sarcoma" target.
Various fractions of cells from the infiltrating cell populations described in Fig. 1 were incubated with autologous target cells in the 51Cr-release test, as well as in the microcytotoxicity test for 18 h. The representative results from 1 out of 4 such experiments performed are shown in Fig. 3 . Cytotoxicity of the autologous "sarcoma") cells was seen in the lowvelocity fractions (2-4 mm/h, peak 3 mm/ h) with both assays. Since the microcytotoxicity test and the isotope test gave the same result, microcytotoxicity was chosen as standard assay in the experiments reported below, due to the limited number of target cells available. As few as 2 x 104 cells produced tumours in 100% (10/10) of the injected mice, whilst 2 x 103 cells gave tumours in 40% (4/10) of the mice. Allogeneic B6D2F1 mice were also injected with the A/Sn "sarcoma' cells and a similar tumour take was observed (Table I ). This is suggestive of virus infection as the main, if not the only source for tumour development. The tumours induced with the "sarcoma" cells regressed in both strains injected.
We also injected a set of mice with 0-2 ml cell-free supernatant collected from overnight cultures of 2 x 106 "sarcoma" cells cultured in 5 ml media. The supernatant was also tumorigenic, as 73% (11/15) Haskill, 1980b) . To determine whether the cytotoxic tumour-infiltrating cells selectively kill virus+ cells, the immunoperoxidase-bridge method was used to stain the assay wells. It was found that the background staining was too high in the microcytotoxicity test wells, so bigger wells were used. In Fig. 4 Characterization of splenic activity against autologous "sarcoma" cells Spleen cells from control as well as normal and anti-lymphocyte globulin (ALG)-treated MSV tumour-bearing (8-13 days after virus inoculation) A/Sn mice were tested against the autologous "sarcoma" cells. Normal spleen cells had no effect on the targets, whereas the MSV spleens at all times after virus inoculation markedly reduced the number of target cells surviving in the tests (Table  III) . Six experiments had similar results. The MSV-spleen effect was not mediated by cytotoxic T cells, as anti-BO and C treatment of (A/Sn x C57BL/6) F1 MSV tumour-bearer spleen cells containing cytotoxic T cells showed the expected reduction in activity against the T-cell-sensitive RB1-5 lymphoma in the 51Cr-release test (data not shown; Becker & Klein, 1980) . Characterization of in situ activity against autologous "sarcoma" targets
The slow-sedimenting fractions (2-4 mm/h) active against autologous "sarcoma" cells (Fig. 3) were pooled and the possible presence of cytotoxic T cells was assessed by treating the cells either with anti-BO serum and C or with medium and C. This treatment did not affect the reduction of "sarcoma" target cells with either MSV-spleen cells or infiltrating cells. Table IV shows one representative experiment of the 5 done.
DISCUSSION
Histological data on MSV tumours indicate that the cell types and tissue organization of these lesions are continuously and progressively changing. At the site of injection, an intense inflammatory response takes place, the lesion containing varying proportions of neutrophils, macrophages, lymphocytes and granulomatous tissue involving histiocytes, fibroblasts and scattered large atypical cells of sarcoma morphology (Berman & Allison, 1969; Stanton et al., 1968; Siegler, 1970) . Under conditions of immunosuppression, the lesion continues to expand until the host dies, thus supposedly proving the malignant nature of the tumour.
The systemic immunity in MSV tumour bearers has been thoroughly investigated and the literature reviewed by Levy & Leclerc (1977) . Several laboratories have tried to relate the systemic studies to the host response within the tumour, in an attempt to identify the important effector mechanisms responsible for regression. Cytotoxic T cells (Plata & Sordat, 1977; Holden et al., 1976; Gillespie et al., 1977; Chapdelaine et al., 1979) , cytolytic macrophages and cytostatic macrophages (Puccetti & Holden, 1979; Russell et al., 1977) have been isolated from enzymedispersed tumours induced both by MSV and by the MSC tumour line established from an MSV-induced sarcoma. Studies carried out on both systemic and intratumoral immunity to MSV in A/Sn mice, however, indicated that cytotoxic T cells are not induced in this strain, suggesting that cytotoxic T cells might not be essential for the regression of MSV-induced tumours (Becker & Klein, 1976 . To date, all the studies on in situ immunity to MSV have used established MLV lymphoma or MSV sarcoma lines as targets. In the present study, considering the controversial nature of the lesion, the possible ambiguities associated with the use of long-term established lines have been removed by the isolation of both target cells (the presumptive sarcoma cells) and the effector cells from the same regressing MSV-induced tumour.
The tumour-isolated target cells were morphologically abnormal. They showed cytoplasmic blebbing, vacuolization and prominent nucleoli, criteria which have been used to characterize transformed cells. In addition, they were nonphagocytic and did not express Fc receptors. Non-cultured "sarcoma" cells, and supernatants from 1-day cultures of "sarcoma" cells, induced tumours when injected into syngeneic as well as allogeneic mice.
These results strongly suggest that reinfection of the second host is a very important mechanism in the successful "transplantation" of the lesion, and thus supports the notion of Simons (1970) (Becker & Haskill, 1980b) (Zinkernagel, 1979) . Also, we wanted to re-examine our previous conclusion (Becker & Klein, 1980 ) that cytotoxic T cells are not generated in response to MSV in the A/Sn strain. Inflammatory cells isolated from the MSV-induced tumours with cytotoxic activity against the "sarcoma"' cells were detected in the slow sedimenting fractions (2-4 mm/h) known to contain cytotoxic T cells in C57BL-6 MSV sarcomas (Holden et al., 1976) . This fraction consisted of small lymphocytelike cells and granulocytes as determined by morphology on cytocentrifuge preparations. Although about 40% of these were T cells, this population was not responsible for the cytotoxicity of the autochthonous target cells. Thus, our previous observations, based on lack of cytotoxic T cells against an MLV-induced lymphoma line, hold also for the autologous MSVinfected target cells (Becker & Klein, 1980) . It is presumed that this reflects the unimportance of cytotoxic T cells in the defence against the in vivo infected, MSVproducing cells responsible for propagation of the lesion.
The in situ effector cells are selectively cytotoxic against the virus-infected "sarcoma"' cells. Non-infected (gp7O negative) presumably reparative fibroblasts in the purified "sarcoma" cell population are not affected in the cytotoxicity assay.
Induced NK cells have been shown preferentially to kill transformed target cells, though normal cells can be suscept-ible also (Welsh et al., 1979; Nunn et al., 1977) . The possibility that NK cells mediate the cytotoxicity has been investigated by comparing the activity profiles on lg-sedimented tumour material against the syngeneic lymphoma line, YAC-1, a highly NK-sensitive target, and the autologous MSV-infected cells. Although the anti-YAC-1 activity in the A/Sn mice (NK-low-reactive strain) is very low, the weak activity was shown to peak at 4*5 mm/h, while the autologous activity peaked at 3 mm/h (Haskill & Becker, 1979) . This suggests that NK cells are not responsible for the effect, but consideration will be given to their possible importance in our further attempts to identify the active cells.
Macrophages have been shown specifically to kill virus-infected cells (Goldman & Hogg, 1978; Chapes & Tompkins, 1979) . Cytotoxic macrophages against lymphoma cells have been identified in MSV-induced tumours (Puccetti & Holden, 1979) . Our higher-velocity fractions contained macrophages. Although these macrophage cell fractions were inactive in the 16h 51Cr-release or microcytotoxicity experiments (Fig. 2) we have been able to show that these cells exert both cytostatic and cytolytic effects against the autologous "sarcoma" cells in 48h assays (Becker & Haskill, 1980b) .
These results, although not conclusively identifying the active cells in the slowsedimenting fractions, do provide strong evidence that the in vivo MSV-infected cells are destroyed by effector cells different from cytotoxic T cells. Recently Leclerc & Cantor (1980) showed that immune Ly 2 3-positive lymphocyte (cytotoxic and memory cells) did not protect mice against MSV-induced tumours, but did protect them against MLV lymphoma growth. Ly 1 cells (helper and DHR cells) on the other hand prevented sarcoma formations. Therefore we believe that MSV tumours, though dependent on an intact thymus-dependent immune system, presumably can regress in the absence of cytotoxic T cells.
